The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene geperpavec) to treat patients with the ultra-rare genetic blistering disease ...

Unexpectedly, dystrophic abnormalities vary in different parts of the brain and also alter with time, Crucially, some of these changes could be reversible, opening the door for targeted therapies.

Metabolic syndrome (MetSyn) is a group of metabolic conditions that occur together and promote the development of type 2 diabetes and cardiovascular disease. These include abdominal obesity ...

Treatment may not be necessary unless they cause pain. These calcifications are common, particularly in the pelvis. They are not usually a cause for concern and are rarely painful. However ...

for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. The CHMP’s positive ...

Among a cohort of multiethnic participants without baseline cardiovascular disease, the presence of extracoronary calcification (ECC) at baseline was independently associated with an increased risk ...